Supernus Pharmaceuticals Announces Q2 2026 Results Release and Call

What Happened
Supernus Pharmaceuticals, Inc. (SUPN) filed an 8-K on July 22, 2026 announcing it will report its second-quarter 2026 financial and business results after the market close on Tuesday, August 4, 2026. The company also said it will host a conference call and webcast on Tuesday, August 4, 2026 at 4:30 p.m. E.T. to discuss the results. A press release dated July 22, 2026 was furnished as Exhibit 99.1 to the filing.

Key Details

• Filing date: July 22, 2026 (Form 8-K, Item 2.02).
• Results release: After market close on Tuesday, August 4, 2026 (second quarter 2026).
• Conference call & webcast: Tuesday, August 4, 2026 at 4:30 p.m. Eastern Time.
• Press release: Furnished as Exhibit 99.1 to the 8-K.

Why It Matters
Quarterly financial results and the accompanying management call are primary sources of updated revenue, profit, and business-progress information for investors. The timing (after market close) and the scheduled webcast mean investors can review the numbers and hear management commentary and Q&A before the next trading day.